YOSH OLIMLAR
ILMIY-AMALIY KONFERENSIYASI
in-academy.uz/index.php/yo
165
GYNECOLOGICAL INFLAMMATORY DISEASES: CAUSES, TREATMENT, AND
PREVENTION
Madumarova Diyorabonu Adkhamjon kizi
Kokand Univercity Andijon branch
Faculty of Medicine treatment direction group 127
https://doi.org/10.5281/zenodo.15551940
Abstract:
This article provides an overview of gynecological inflammatory diseases
(GIDs), including their causes, pathogenesis, clinical manifestations, and modern treatment
approaches. Additionally, preventive measures to reduce the incidence and complications of
these conditions are discussed. The article is intended for medical students, healthcare
professionals, and the general public.
Keywords:
gynecological inflammation, infection, endometritis, oophoritis, antibiotics,
prevention.
Introduction:
Gynecological inflammatory diseases (GIDs) affect various parts of the
female reproductive system and can be caused by infectious or non-infectious factors.
Common conditions include cervicitis (inflammation of the cervix), endometritis
(inflammation of the uterus), and salpingo-oophoritis (inflammation of the fallopian tubes
and ovaries). These diseases can negatively impact women’s overall health and fertility. Early
diagnosis and appropriate treatment can help minimize complications and improve outcomes.
Etiology and Risk Factors: Infectious Causes: Bacterial infections:
Chlamydia
trachomatis,
Neisseria
gonorrhoeae,
Mycoplasma,
Ureaplasma,
Streptococcus,
Staphylococcus
. Viral infections:
Herpes simplex virus, human papillomavirus (HPV).
Fungal infections:
Candida species.
Parasitic infections:
Trichomonas vaginalis.
Non-Infectious Causes:
Hormonal imbalances. Weakened immune system.Surgical
interventions (abortions, intrauterine device placement). Poor hygiene and exposure to cold
temperatures.
Risk Factors:
Unprotected sexual intercourse. Multiple sexual partners. Improper use of
antibiotics. Smoking and unhealthy diet.Chronic stress and fatigue.
Pathogenesis:
Infectious agents can ascend through the reproductive tract, leading to
inflammation in the uterus, fallopian tubes, or ovaries. This results in swelling, pain, and
functional impairment. If left untreated, the disease may become chronic, increasing the risk
of infertility and other complications.
Clinical Manifestations: Acute Phase:
Lower abdominal pain. Heavy purulent or
bloody vaginal discharge. Fever. Weakness and general malaise.
Chronic Phase:
Persistent or recurrent pelvic pain. Irregular menstrual cycles.
Discomfort or pain during intercourse. Difficulty conceiving.
Diagnosis:
Gynecological examination (evaluation of the uterus and adnexa).Laboratory
tests (bacteriological culture, PCR tests for infections). Ultrasound (USG) (assessment of
changes in the uterus and ovaries). Colposcopy and biopsy (if necessary).
Treatment Approaches: Pharmacological Therapy;
Antibiotics: broad-spectrum
agents (doxycycline, azithromycin, metronidazole). Antiviral drugs: for herpes or HPV-related
infections.Antifungal medications: for candidiasis. Anti-inflammatory drugs: NSAIDs
(ibuprofen, diclofenac). Immunomodulators: to strengthen the immune response.
YOSH OLIMLAR
ILMIY-AMALIY KONFERENSIYASI
in-academy.uz/index.php/yo
166
Physiotherapy:
Magnetic therapy, electrophoresis, laser therapy – useful for chronic
conditions. Surgical Interventions
.
In severe cases, abscess drainage or removal of affected
tissues may be required.
Prevention:
Maintaining personal hygiene. Practicing safe sex (using condoms, regular
screening for STIs). Undergoing regular gynecological check-ups (at least once or twice a
year). Adopting a healthy lifestyle (balanced diet, physical activity, stress management).
Avoiding self-medication.
Conclusion:
Gynecological inflammatory diseases pose significant health risks to
women, potentially leading to infertility and other complications. Early diagnosis and
appropriate treatment are crucial for improving reproductive health outcomes. Preventive
measures play a key role in reducing the incidence of these diseases and ensuring overall
well-being.
References:
Используемая литература:
Foydalanilgan adabiyotlar:
1.
Cunningham, F. G., Leveno, K. J., Bloom, S. L., Spong, C. Y., Dashe, J. S., Hoffman, B. L.,
Casey, B. M., & Sheffield, J. S. (2021). Williams Obstetrics, 26th Edition. McGraw Hill.
2.
Sweet, R. L., & Gibbs, R. S. (2018). Infectious Diseases of the Female Genital Tract, 6th
Edition. Wolters Kluwer Health.
3.
Workowski, K. A., & Bolan, G. A. (2021). “Sexually Transmitted Infections Treatment
Guidelines, 2021.” MMWR Recommendations and Reports, 70(4), 1-187.
4.
Hager, W. D., Eschenbach, D. A., Spence, M. R., & Sweet, R. L. (2019). “Pelvic Inflammatory
Disease: Current Concepts in Pathogenesis, Diagnosis, and Treatment.” Obstetrics &
Gynecology, 134(3), 467-479.
5.
Sherris, J., & Ryan, K. J. (2019). Medical Microbiology and Immunology: Examination and
Board Review, 15th Edition. McGraw Hill Education.
6.
World Health Organization (WHO). (2022). Sexually Transmitted Infections: Policy Brief
on Prevention and Treatment Strategies. WHO Publications.
7.
Centers for Disease Control and Prevention (CDC). (2021). Pelvic Inflammatory Disease
(PID) – Clinical Overview and Management Guidelines. CDC Website: www.cdc.gov
(https://www.cdc.gov/)
8.
Reid, G., Younes, J. A., Van der Mei, H. C., Gloor, G. B., Knight, R., & Busscher, H. J. (2018).
“Microbiota Restoration and Biotherapeutic Approaches in Vaginal Health.” Frontiers in
Microbiology, 9, 1941.
9.
Racicot, K., & Mor, G. (2017). “Risks Associated with Bacterial Vaginosis in Pregnancy:
From Preterm Labor to Maternal-Fetal Infections.” Journal of Clinical Investigation, 127(4),
1121-1129.
10.
Kovachev, S. (2020). “Probiotics in the Prevention and Treatment of Bacterial Vaginosis
and Urinary Tract Infections.” International Journal of Women’s Health, 12, 541-551.
